European regulators recommended a subcutaneous formulation for a key anti-CD38 therapy, offering clinicians and patients more flexible administration options for multiple myeloma.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/ema-backs-new-delivery-route-anti-cd38-myeloma-drug-2026a10009nt?src=rss
Author :
Publish date : 2026-03-30 14:35:00
Copyright for syndicated content belongs to the linked Source.